ClinicalTrials.gg
Sign In

Angina Pectoris, Variant clinical trials

The registry lists 34 studies for Angina Pectoris, Variant across more than 10 countries. 10 are recruiting or about to start. 18 of them are mainly about Angina Pectoris, Variant (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Angina Pectoris, Variant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
10
Recruiting
9
Status unknown
8
Active, not recruiting
3
Withdrawn
2
Enrolling by invitation
1

Phase

Phase 4
8
Phase 2
4
Phase 3
4

Where

Korea, Republic of
11
Netherlands
5
United States
4
Poland
3
China
3
United Kingdom
2

Who runs them

Korea Otsuka Pharmaceutical Co., Ltd. (3) · Radboud University Medical Center (2) · Roxane Laboratories (2) · Seung-Jung Park (2) · Samsung Medical Center (2) · Luzerner Kantonsspital (1) · NHS Greater Glasgow and Clyde (1) · Yonsei University (1)

What is being tested here

Drugs under test in Angina Pectoris, Variant studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Amlodipine113
Nebivolol111
Atorvastatin003
Cilostazol022
Nitrates001
Vericiguat001
Ascorbic Acid001
Vitamin E001
Bisoprolol001
Diltiazem001

Drug classes tested here Calcium channel blockers 1 open

Coming up

2phase 3 studies under way
3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Who these studies take

Of the 9 Angina Pectoris, Variant studies recruiting now, 8 (89%) set no upper age limit and 1 (11%) stop at 75 or younger. 1 (11%) take children under 18. 1 (11%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
101 (11%)1 (11%)
188 (89%)8 (89%)
308 (89%)8 (89%)
409 (100%)8 (89%)
509 (100%)8 (89%)
659 (100%)8 (89%)
759 (100%)8 (89%)
858 (89%)8 (89%)

Across all 34 studies, recruiting or not: 15% stop at 75 or younger and 6% at 65; 15% take children; 6% are for women only and 3% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 34 of 34. search them.